^
BIOMARKER:

BCR-ABL1 V299L

i
Other names: BCR, BCR Activator Of RhoGEF And GTPase, BCR, RhoGEF And GTPase Activating Protein, Breakpoint Cluster Region Protein, Renal Carcinoma Antigen NY-REN-26, Breakpoint Cluster Region, D22S11, BCR1, BCR/FGFR1 Chimera Protein, FGFR1/BCR Chimera Protein, D22S662, ALL, CML, PHL, ABL proto-oncogene 1, ABL, c-ABL, JTK7, p150, ABL1
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
BCR-ABL1 V299L
Acute Lymphocytic Leukemia
dasatinib
Resistant
:
A2
BCR-ABL1 V299L
Chronic Myeloid Leukemia
bosutinib
Resistant
:
A2
BCR-ABL1 V299L
Chronic Myeloid Leukemia
dasatinib
Resistant
:
A2
BCR-ABL1 V299L
Acute Lymphocytic Leukemia
bosutinib
Resistant
:
A2
BCR-ABL1 V299L
Chronic Myeloid Leukemia
nilotinib
Sensitive
:
D
BCR-ABL1 V299L
Acute Lymphocytic Leukemia
crizotinib
Sensitive
:
D
BCR-ABL1 V299L
Acute Lymphocytic Leukemia
GSK1363089
Sensitive
:
D
BCR-ABL1 V299L
Acute Lymphocytic Leukemia
cabozantinib capsule
Sensitive
:
D
BCR-ABL1 V299L
Acute Lymphocytic Leukemia
vandetanib
Sensitive
:
D
BCR-ABL1 V299L
Chronic Myeloid Leukemia
imatinib
Sensitive
:
D